What Are Complications of Using Riboflavin–UV-A Corneal Collagen Cross-Linking to Treat Keratoconus?

March 15, 2011

Submit Comments
Dr. Ari Weitzner

The March 2011 issue of the Archives of Ophthalmology reports on research investigating complications from using riboflavin–UV-A corneal collagen cross-linking (CXL) to treat keratoconus.

Prior research has identified stromal haze formation and permanent stromal haze as complications of CXL (albeit the cases involved relatively mild haze and eyes with advanced keratoconus).

Click here to access the article.

 

 

Print this post
 

Bookmark

 
Filed in Cornea, Research Tagged , ,


Comments

Jump down to form below to submit your own comments

3 Responses to “What Are Complications of Using Riboflavin–UV-A Corneal Collagen Cross-Linking to Treat Keratoconus?”

  • ari
    on September 21, 2012 10:12 am

    it strengthens the cornea and can minimize progression or even improve its shape.

  • Delores Underwood
    on September 20, 2012 4:39 pm

    Interesting Information. Do you know the advantages of doing this surgery?

  • Keratoconus Treatment
    on March 18, 2011 4:12 am

    Wow thanks for this information I am about to get a keratoconus treatment done and now will be looking into it more after reading this. Thanks!